Weight loss medications, specifically GLP1 agonists like Ozempic Wegovy and Mounjaro, are redefining the landscape of healthcare in Britain, with new research signposting not only longer lives for millions but
All posts tagged in GLP1 agonists
2Articles
A new oral medication weight loss, orforglipron, has shown promising results in a landmark trial, marking a significant step for obesity treatment in the UK. Developed by Eli Lilly, orforglipron
